From: Potential impact of host immunity on malaria treatment outcome in Tanzanian children infected with Plasmodium falciparum
GLURP-R0
GLURP-R2
Treatment and group SP
Presence of antibody/resistant haplotype*
TF
ACPR
1
+/-
2
4
6
-/-
3
5
+/+
7
9
-/+
22
19
AQ
0
8
12
11
13